You searched for "hearing"
Immunosuppresants and ototoxicity
There is a wide range of immunosuppressant drugs ranging from calcineurin inhibitors (e.g. cyclosporine), anti-folic agents (e.g. methotrexate) to anti-TNF and monoclonal antibodies, many of which could be ototoxic. The authors performed a systematic review assessing ototoxicity secondary to immunosuppressant...To make a difference
Education and training have a key part to play in the development of leaders of the future; Dorte Hammershøi discusses the educational approaches taken in Denmark and the pros and cons of the methods used. Dorte also explains the BEAR...
Are we all in the matrix?
In the entirety of training and in further practice, we are instilled with the premise of patient-centred care and individualised management plans based on informed consent. The question in the new age of telehealth/e-health is how to mimic that personalisation...In conversation with Shelly Chadha 2019
Shelly Chadha works at the World Health Organisation as the Medical Officer for ear and hearing care. Here, Alex Griffiths-Brown interviews her to find out more about her career, challenges she’s faced and her ambitions for the future. Shelly Chadha....In conversation with Shelly Chadha 2019
Shelly Chadha works at the World Health Organisation as the Medical Officer for ear and hearing care. Here, Alex Griffiths-Brown interviews her to find out more about her career, challenges she’s faced and her ambitions for the future. Shelly Chadha....Sound Seekers: audiology in the developing world
Kavita Prasad, the current CEO of Soundseekers, is an inspirational woman in a leadership role within the audiology world. Here, she gives us an overview of the scope of the charity and the ways in which they improve the lives...
Outcomes at three years post-implantation of the Bonebridge device
This is a MED-EL-funded study of the hearing outcomes and complication rates of the Bonebridge active transcutaneous bone conduction implant (BCI). The authors have declared no conflict of interest. Follow-up occurred at intervals for 36 months post-implantation in all 57...Cochlear implants and therapeutics: a natural partnership?
Global awareness of cochlear implants as a solution for hearing loss is slowly increasing and gaining acceptance. The potential for combining cochlear implants with inner ear therapeutics is immense, with promise in several areas. This article takes us on a...
Cochlear implants in single sided deafness
Whilst the benefit of a second cochlear implant in people with bilateral deafness is well established, the benefits of implantation for single sided deafness with normal contralateral hearing have been much more modest. The reasons for this are varied, in...
Follow-up of NF2 patients with ABRs, SDS and MRI
Hearing loss is one of the earliest manifestations in vestibular schwannomas with 60% of the patients having high frequency loss. Several metabolic and mechanical factors influencing the cochlea and cochlear nerve have been implicated in the hearing decline noted in...
Transcutaneous vs. percutaneous bone conduction devices
Bone conduction devices (BCD) have proven to be effective options for hearing amplification in patients who are not candidates for conventional hearing aids. This study prospectively surveyed 70 patients with BCD using the COSI (Client Oriented Scale of Improvement) and...
